We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Mammograms May Help Screen for Heart Disease

By HospiMedica International staff writers
Posted on 03 Apr 2016
Print article
Routine mammography screening for breast cancer may be a useful tool to identify coronary arterial calcification (CAC), according to a new study.

Researchers at Mount Sinai St. Luke's Hospital (New York, NY, USA) and the Icahn School of Medicine at Mount Sinai (New York, NY, USA) conducted a study involving 292 women who had both digital mammography and non-contrast computerized tomography (CT) scans within one year of each other. Examination of the data showed that 42.5% of the women had evidence of breast arterial calcification. The mammograms were reviewed by a second radiologist, who was blinded to the CAC results found on the CT scans. Women with established cardiovascular disease (CVD) were excluded.

The results showed that the overall accuracy of breast arterial calcification for the presence of CAC was 70%, while 63% of the women with CAC also had breast arterial calcification. Among women younger than 60 years of age, breast arterial calcification showed a higher, 83% risk for CAC. Additional findings were that women with breast arterial calcification were older, had high blood pressure and chronic kidney disease (CKD), and were less likely to be smokers. The study was presented at the American College of Cardiology (ACC) 65th annual scientific session, held during April 2016 in Chicago (IL, USA).

“This information is available on every mammogram, with no additional cost or radiation exposure, and our research suggests breast arterial calcification is as good as the standard risk factor-based estimate for predicting risk,” said lead author Prof. Harvey Hecht, MD, director of cardiovascular imaging at Mount Sinai St. Luke's Hospital. “Using this information would allow at-risk women to be referred for standard CAC scoring and to be able to start focusing on prevention—perhaps even taking a statin when it can make the most difference.”

CAC is considered a very early sign of CVD, and the presence of breast arterial calcification appears to be an equivalent or stronger risk factor for CAC than other well-established CVD risk factors, such as high cholesterol, high blood pressure, and diabetes. Research has also shown a link between breast arterial calcification and atherosclerotic disease, as well as a relationship between the extent of calcified plaque in the mammary and coronary arteries.

Related Links:

Mount Sinai St. Luke's Hospital
Icahn School of Medicine at Mount Sinai


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.